Share
Export Citation
APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journal›Article›peer-review
The preclinical and clinical trials of mesenchymal stem cell’s secretome in traumatic brain injury: Review of basic science
Yudha I.G.A.A.
Surgical Neurology International
Q3Published: 2025Citations: 1
Abstract
Compared with traditional therapies, MSC and secretome treatment can directly improve TBI-induced pathological changes and promote recovery of neurological function. MSCs and their secretome hold great promise to bridge this gap in translation for TBI. Further clinical trials are needed to confirm its efficacy and safety.
Access to Document
10.25259/SNI_1025_2024Other files and links
- Link to publication in Scopus
- Open Access Version Available
Fingerprint
Traumatic brain injurySciences
MedicineSciences
Mesenchymal stem cellSciences
NeuroprotectionSciences
NeuroinflammationSciences
Clinical trialSciences
ImmunogenicitySciences
BioinformaticsSciences
Immune systemSciences
NeuroscienceSciences
InflammationSciences
ImmunologySciences
PathologySciences
PharmacologySciences
BiologySciences
PsychiatrySciences